1. Otsuka Pharmaceutical (2014). Abilify (prescribing information). Available from: http://www.otsuka-us.com/documents/Abilfy.PI.pdf . Accessed 16 Mar 2016.
2. Hahn M, Braus DF. Psychiatric polypharmacy: hazard through drug-drug interaction and possibilities for prevention. Versicherungsmedizin. 2012;64(3):127–31.
3. Hahn M. Wenn Wechselwirkungen den Therapieerfolg gefährden. Neurologie Psychiatrie. 2012;14(5):58–64.
4. Otsuka Pharmaceutical (2014). Abilify (package insert). Available from: http://packageinserts.bms.com/pi/pi_abilify.pdf . Accessed 16 Mar 2016.
5. Seden K, Merry C, Hewson R, et al. Prevalence and type of drug-drug interactions involving ART in patents attending a specialist HIV outpatient clinic in Kampala, Uganda. J Antimicrob Chemother. 2015;70(12):3317–22.